Novobiocin sodium salt, novobiocin sodium salt and 1 more item

The University of Virginia awarded contract A207_PO-0469788 to Sigma-Aldrich Inc on August 15, 2026, for the procurement of specialized pharmaceutical compounds. The contract, valued at $272.00, encompasses the delivery of two distinct line items to Mahendra Devichand Chordia. The prime contractor is supplying Novobiocin Sodium Salt at a unit price of $217.00 and Tedizolid at a unit price of $55.20, each in a quantity of one unit.

This Virginia-based contract represents a limited procurement of research or laboratory-grade pharmaceutical materials. The specific compounds—Novobiocin Sodium Salt, an antibiotic substance, and Tedizolid, a oxazolidinone-class antibiotic—indicate the materials are likely intended for research, testing, or institutional use within the University of Virginia's operations. The modest cumulative contract value and single-unit quantities suggest this is a targeted procurement to support specific institutional requirements rather than a large-scale supply agreement.